© 2020 MJH Life Sciences and OncLive. All rights reserved.
May 20, 2020
Peter Voorhees, MD, discusses the benefit of monoclonal antibodies in multiple myeloma.
May 19, 2020
May 02, 2020
Peter Voorhees, MD, discusses the evolution of idecabtagene vicleucel (ide-cel; bb2121) in the phase 2 KarMMa study in relapsed/refractory multiple myeloma.
February 05, 2020
Peter Voorhees, MD, discusses the role of CAR T-cell therapy in multiple myeloma.